We show that UVA irradiation (365nm) of the Pt(IV) complex trans,trans,trans-[Pt(IV)Cl(2)(OH)(2)(dimethylamine)(isopropylamine)] (1), induces reduction to Pt(II) photoproducts. For the mixed amine Pt(II) complex, trans-[Pt(II)Cl(2)(isopropylamine)(methylamine)] (2), irradiation at 365nm increases the rate and extent of hydrolysis, triggering the formation of diaqua species. Additionally, irradiation increases the extent of reaction of complex 2 with guanosine-5'-monophosphate and affords mainly the bis-adduct, while reactions with adenosine-5'-monophosphate and cytidine-5'-monophosphate give rise only to mono-nucleotide adducts. Density Functional Theory calculations have been used to obtain insights into the electronic structure of complexes 1 and 2, and their photophysical and photochemical properties. UVA-irradiation can contribute to enhanced cytotoxic effects of diamine platinum drugs with trans geometry.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933825PMC
http://dx.doi.org/10.1016/j.jinorgbio.2010.04.009DOI Listing

Publication Analysis

Top Keywords

diamine platinum
8
irradiation 365nm
8
photoactivation trans
4
trans diamine
4
platinum complexes
4
complexes aqueous
4
aqueous solution
4
solution reactivity
4
reactivity nucleotides
4
nucleotides uva
4

Similar Publications

Schiff Base-platinum and ruthenium complexes and anti-Alzheimer properties.

J Inorg Biochem

November 2024

Department of Chemistry, Faculty of Science, Ege University, Bornova, Izmir 35100, Turkey. Electronic address:

This study investigates the effects of Pt and Ru complexes containing a Schiff base with a diimine structure on Alzheimer's disease. The Schiff base (N1E,N2E)-N1,N2-bis(isoquinolin-4-ylmethylene)benzene-1,2-diamine (I) and the novel Pt(II) and Ru(II) complexes (Ia and Ib) were synthesized and characterized using FTIR, NMR (H, C), mass spectrometry, and elemental analyses. Their ability to inhibit amyloid beta (Aβ) aggregation was determined in vitro using the SH-SY5Y cell line.

View Article and Find Full Text PDF

Cis-dichlorodiammineplatinum(II) (CDDP), while widely utilized in tumor therapy, results in toxic side effects that patients find intolerable. The specific mechanism by which CDDP inflicts ovarian damage remains unclear. This study aimed to explore the involvement of ferrostatin-1 (FER-1) and ferroptosis in CDDP-induced ovarian toxicity.

View Article and Find Full Text PDF

In the upcoming decades, the incidence and mortality rates of cancer are expected to rise globally, with colorectal and prostate cancers among the most prevalent types. Despite advancements in molecular targeted therapy, platinum-based chemotherapies remain the cornerstone of treatment, especially for colorectal and prostate cancer, with oxaliplatin and cisplatin being extremely effective due to their DNA-targeting capabilities. In our pursuit of new platinum-based chemotherapeutics that are potentially less toxic and more effective, we have explored the combination of the Pt-binding groups of the diaminocyclohexane ring used in oxaliplatin, with the stable amino-pyrimidine hemicurcumin moiety.

View Article and Find Full Text PDF

Platinum(II)-Salphen Complexes as DNA Binders and Photosensitisers.

Chemistry

November 2024

Department of Chemistry, Imperial College London, White City Campus, London, W12 0BZ, United Kingdom.

Current anticancer therapies suffer from issues such as off-target side effects and the emergence of drug resistance; therefore, the discovery of alternative therapeutic approaches is vital. These can include the development of drugs with different modes of action, and the exploration of new biomolecular targets. For the former, there has been increasing interest in drugs that are activated by an external stimulus (e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!